| 27241-204 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-204-30 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-205 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-205-30 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-206 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-206-30 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-207 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-207-30 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-208 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-208-30 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-209 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 27241-209-30 | These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015 | Ajanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej |
| 59148-035 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-035-13 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-036 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-036-07 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-036-13 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-037 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | REMEDYREPACK INC. |
| 59148-037 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-037-07 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-037-13 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-038 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | REMEDYREPACK INC. |
| 59148-038 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-038-07 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-038-13 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-039 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-039-07 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-039-13 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-040 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-040-07 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-040-13 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-042 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-042-07 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-044 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 59148-044-14 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | Otsuka America Pharmaceutical, Inc. |
| 70518-3548 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | REMEDYREPACK INC. |
| 70518-3548-0 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | REMEDYREPACK INC. |
| 70518-3548-1 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | REMEDYREPACK INC. |
| 70518-3548-2 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | REMEDYREPACK INC. |
| 70518-4608 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | REMEDYREPACK INC. |
| 70518-4608-0 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | REMEDYREPACK INC. |
| 70518-4608-1 | These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015 | REMEDYREPACK INC. |